The effect of oral tacrolimus with rectal indomethacin to reduce pancreatitis
Not Applicable
- Conditions
- Pancreatitis after ERCP.Other acute pancreatitisK85.8
- Registration Number
- IRCT20240327061376N1
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 78
Inclusion Criteria
Normal amylase and lipase levels before ARCP
All patients who meet the criteria for performing RCPI
Having informed consent
Full consciousness
• No contraindications for tacrolimus
Exclusion Criteria
Pregnancy or breastfeeding
History of previous angina, myocardial infarction, cerebral ischemia during the previous three months
• Chronic heart, liver and kidney failure
Referral with manifestations of acute pancreatitis or chronic pancreatitis
• Tacrolimus contraindications include: uncontrolled blood pressure, uncontrolled infections, hypomagnesemia, hypocalcemia, hyperkalemia, and any type of malignancy.
• Heart rhythm disorders
• Thrombosis and DVT
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method